Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great work. Very reasonable estimate. Add in new product increases and we will hit $120mm for 2021
Agree 100%. JUstin is not giving big discounts either for financiers or new hires. He knows what he is doing and has a network that is exceptional. With the company's demonstrated consistent outsized growth rate, its ability to add new product lines w/i VeritasMD, its ease of raising growth capital and now the new Telemedicine focus Justin will be able to pick and choose new product licenses from small Pharma companies with great products and limited marketing ability. Price targets are ramping up IMO.
Thanks for posting.
This takes CVLB or LFMD to a new level of Virtual Concierge Medicine and reflects the pioneering views of recent additions to the Medical Team. This new development will further tie patients to the company, fuel building ARR, and accommodate multiple revenue opportunities with patients. The private placement of $14 mm supports massive future growth.
Time to adjust future price target!
Today's profit taking by S-T traders is setting a more solid base for the next leg up next week. buyers taking the offered shares will not be selling any time soon and the ride continues next week.
We hit $32.97 around 1:00. Strong volume today.
Hit $31.89 at opening
CVLB is at $29.50 pre-market trading this a.m. With the normal opening surge we should hit $32.
In pre-market trading we hit $30.97. Now $29.76. Should be another good day.
Strong balance sheet especially for developing company. The cash position says marketing power. Current ratio says highly bankable for additional non-dilutive financing.
Justin built a solid foundation. He is not just about ripping new sales, but has set up a growth sustaining organization. The stable of social media marketers, the state of the art customer service installation, and Veritas front to back integrated operating module all accommodate rapid and sticky growth and launch of new product lines. Justin has an institutional focus, not simply a growth focus.
Agreed
Analyst is using $70 mm estimate. It has been informally indicated at $100 mm. $45 to $50 is about right
Referring to my last post, the short sellers must be concerned by the B. Riley BUY and $35 price target. They are working hard this a.m. to keep the price from getting away from them but not too successfully. Despite B. Riley's ( by the way a very respected and growing firm) endorsement, they are still light on 2021 estimated sales at $70 mm. Justin's informal estimate is higher so we will blow through $35 the same way we blew through $15.
Interesting take on CVLB by STOCK REGISTER.COM
Conversion Labs, Inc. (NASDAQ:CVLB) is an exciting stock to watch
They indicate trading volume for past 3 months averaged 446 K /day, while during the past 10 days the average was 2.03 mm.
Thirty-seven % of shares are held by insiders. (Another 10% to 15% is owned by long term shareholders like me and about 10 others that I know who have held for more than 10 years and are not in need to raise cash) That means the float is probably 11 mm shares. If Stock register is to be believed, short sales totaled 5.22 mm in December. At half the flost and with a 240% stock price since the beginning of the year the shorts are in bog trouble. This may explain the selling designed to push vack the early gains that occur almost every trading day in pre-market and at the beginning of trading.
So when the next analyst begins coverage with a BUY (and that will be happening soon) and when the Q4 and 2020 results print about mid- month and when the company announces successful launch of the new skin care line and its new celebrity spokes person this month and next (RX first, then OTC)and when the next licensing agreement or JV is announced the shorts will help us long-term investors push the surge in the stock price.
The traders hit CVLB today. we rallied back to near yesterday's clos twice but we were hit with selling at the end. Despite that action CVLB moved up $.60 after closing. Tomorrow is another day.
A small consolidation with rally attempts sets up a new foundation to continue the upward trend. Look for CVLB to push back toward $28 by end of this week.
I think you are right. When imbalances occur the broker dealers who maintain a smooth functioning market must take a short breather to insure that contracts can be fulfilled. This is something that new investors do not understand about trading stops in general. They are not necessarily a sham to protect the institutions.
Short will be short lived. We are back up to $24.16
More likely 2021 revenue will be $100 to $120 mm. Even if CVLB trades up to 14 x, at $100 mm we would expect $60/sh.
Should be 1 or 2 more analysts initiating coverage soon. This will create more interest and propel the valuation toward what it should be ---at least $40/sh.
More eyeballs. They are prescient. The new Medical/Compliance officer is a critical risk management resource ti maintain integrity and reputation.
Up $.32 in after hours trading to $20.82!
Company is in process of hiring spokesperson for the new Skin products lines (both RX and OTC). Looking forward to the announcement.
Nice recovery on high volume totaling $40 mm in volume. Added $1.60 to last closing high
Back on track. Surge in buying around 10:00 350,00 shares pushed us up to $20.40. Settled down to $19.89 now.
Traders hurt us today. CVLB rallied back 3 times, but traders took their gains and buyers were selective perhaps even selling small amounts to push price down further before making a larger buy.
Tomorrow is another day. CVLB undervalued vs comparisons, growth, infrastructure, SARR gains, etc.
Indicates that people WANT IN.
Plan is to sell or spin off at a certain point.
There are slso at least a dozen very long-term investors like me who have held for more than a decade and who are not going anywhere. Probably accounts for another 3 mm shares.
Shorts have been negligible. This is the result of Justin talking to institutional investors. The volume is larger every day for last 4 days. $47 mm in dollar volume today is institutional buying. IMO more to come.
I little consolidation at this point would be healthy as it sets a new foundation for moving higher. recent buyer are buying at relatively higher prices, are more sophisticated and/or institutions and would have a longer time horizon. As long as execution holds we have a near term (3 months) run IMO.
You got that right!!!!
Today's trading formed a flag pattern that seems almost certain to be resolved to the upside, due to the large volume and overall trend.
CVLB halted twice today. Reason : Volatility Trading. Two periods of massive buying (for this stock) by institutions caused price surges. Investors and traders will become aware of this over the weekend. Augers well for Monday and early next week action. Should hit $14 or more.
It doesn't Have to do anything. It can continue rising at 15% per trading day for a few more days and then just level off in a choppy pattern at around $14.
Why would there be a pullback? Volume is building. Selling backing off. We expect 2 or 3 analysts to begin coverage very soon.
CVLB pushed through previous resistance of $9.25 and is $.56 (5.5%) from all time high.
Seeking Alpha discussion board is very bullish on CVLB. Consensus value now is $12.25. Generally Buy and HOld. Some see $55 at end of year.
CVLB up to $8.00 today. Lots of buying, selling retrained. Up, Up and Away!!!
Growth awesome and accelerating in Q4. ARR at $26 mm is phenomenal. Expectations for growth to accelerate throughout 2021. Buckle up.
Thanks. The frustration may be from the trading and profit taking. We look at CVLB and think that with the array of achievements, why would anyone sell? But some people are happy with a nice gain and move on. Let them The people over the past few weeks who bought near daily highs (of $8 and $9) before traders and sellers pushed the price down are apt to be stronger, longer term and patient investors who got on the train to ride it up to $15, $20, or more, so the selling will decline sometime soon.
Possibly mental wellness -- proven supplements for mental acuity, mood enhancement, etc. You are on to something re. accumulation. People definitely are buying and lots. Volume is very significant and rising. There are a lot of people sitting on 400% and 500% gains this past year, so some are definitely re deploying assets. This limits gains in s-t. BUT revenues and earnings announcements in Jan and Feb AND 2 more or more analysts initiating coverage and a price breakthrough to a new level is imminent. We could be at $12-$14 in 6 weeks.